ISRCTN89357177进行中（未招募）未知
Evaluation of the Level 4 Group Triple P: Positive Parenting Program®
Education Endowment Foundation0 个研究点目标入组 1,100 人开始时间: 2019年7月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. The setting is located in the areas for recruitment determined by the EEF and the Delivery team
- •2. The setting has not had Triple P or Incredible Years delivered to 3 and 4 year olds since 1 January 2018
- •3. The setting is not actively involved in any other EEF Home Learning Environment Trial
- •1. Children are 3 or 4 years old
- •2. The teacher is concerned about a delay in a child's language/communication development. The SDQ-T will be used to support the identification of children as appropriate for Level 4 Group Triple P (more details on the SDQ-T follow in the section on Outcome measures); OR
- •3. The teacher or parent is concerned about a child’s behavioural, emotional or social development; OR
- •4. The practitioners decide that there is an indicator of increased family vulnerability, such as: family social disadvantage, financial stress, housing insecurity, adverse life events. In many early years settings, there is a home visit by setting staff before the start of the academic year, meaning that practitioners will have a better idea about the family’s situation. Many early years staff will also have at-the-door” conversations when children are picked up/dropped off where parents may also discuss any concerns about the child
- •Parents/Carers:
- •1. They understand and speak English
- •2. They have not attended either Triple P or Incredible Years parenting programmes since January 2018
- •3. They agree that they and their child can participate in the research and that they will attend the eight-week programme in the Spring term 2020, if allocated to the intervention group
排除标准
- •Parents with severe psychological illness cannot be excluded prior to initial contact with practitioner, as the practitioner may be unaware of their psychological state. However, it is suggested that their inclusion is avoided if this information later comes to light as these parents will have difficulties engaging in the programme.
研究者
相似试验
已完成
不适用
Evaluation of the efficacy of Group Triple P – Positive Parenting Program to enhance co-parenting practices among Vietnamese generations: Randomized Controlled TrialIntergenerational conflict in parentingACTRN12617001209381April Hoang120
进行中（未招募）
1 期
4head User Evaluation.Tension-type headaches.EUCTR2005-003505-85-GBDermal Laboratories Limited22
已完成
不适用
Preliminary evaluation of Fear-less Triple P for parents of anxiety-disordered childreAnxiety disorders in childrenMental Health - AnxietyACTRN12615000514505Vanessa Cobham60
进行中（未招募）
不适用
AN OPEN-LABEL, UNCONTROLLED PHASE 4 STUDY TO ASSESS THE SAFETY AND IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS (JE) VACCINE IXIARO® (IC51) IN AN ELDERLY POPULATION - IC51-315IXIARO® is used to protect adults against Japanese encephalitis (JE). JE can be fatal or lead to long-term disability. Vaccination with Ixiaro should be considered for people who are at risk of exposure to the JEV through travel or work. A post-marketing requirement was to collect more safety and immunogenicity data in elderly, therefore this study is to be performed in healthy volunteers = 65 years of age.MedDRA version: 12.1Level: LLTClassification code 10014596Term: Encephalitis Japanese BMedDRA version: 12.1Level: LLTClassification code 10023119Term: Japanese B encephalitisMedDRA version: 12.1Level: LLTClassification code 10023120Term: Japanese B viral encephalitisMedDRA version: 12.1Level: LLTClassification code 10023122Term: Japanese B virus encephalitisMedDRA version: 12.1Level: LLTClassification code 10023123Term: Japanese encephalitisEUCTR2010-018630-52-DEIntercell AG200
进行中（未招募）
不适用
AN OPEN-LABEL, UNCONTROLLED PHASE 4 STUDY TO ASSESS THE SAFETY AND IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS (JE) VACCINE IXIARO® (IC51) IN AN ELDERLY POPULATION - IC51-315EUCTR2010-018630-52-ATIntercell AG200